DSM launches OatWell Oat Beta-Glucan Product
date:May 15, 2013
The market for functional products targeting heart health is booming, with the global industry predicted to be worth $15.2 billion by 20181 as consumer awareness and the body of scientific research grows.

Ruedi Duss, global business manager for OatWell at DSM, comments: As the first grain-based product to be recognised by EFSA as having cholesterol reducing benefits, OatWell oat beta-glucan is a great addition to DSMs portfolio of heart healthy nutritional ingredients. Backed by strong scienc
3/5 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/17 13:16